3 Chemicals Sugar and Agri Business Company, Diagnostics Chain and Water Treatment Solutions Company Stocks With a Strong Future Roadmap: DCM Shriram, Vijaya Diagnostic Centre and Ion Exchange (India)
- November 10, 2026
- Posted by: Kunal Singla
- Category: Best Stocks
DCM Shriram, Vijaya Diagnostic Centre and Ion Exchange (India): ROE of 10.7% to 18.1% and FY22 to FY26 revenue CAGR of 9.0% to 16.7%. Prices as of 9 Nov 2026.
Quick Answer
The three chemical and sugar, diagnostic and water stocks to watch are DCM Shriram, Vijaya Diagnostic Centre and Ion Exchange (India). Their return on equity ranges from 10.7% to 18.1%, and their revenue compound annual growth from FY22 to FY26 ranges from 9.0% to 16.7%. Vijaya Diagnostic Centre has the highest return on equity at 18.1%, while Ion Exchange (India) has the fastest revenue growth at 16.7% a year. Prices are based on the 9 November 2026 close, and this article is educational, not investment advice.
Chemical and sugar, diagnostic and water stocks let investors follow companies that serve a growing part of the Indian economy. DCM Shriram, Vijaya Diagnostic Centre and Ion Exchange (India) cover a chemicals, sugar and agri business company, a diagnostics chain and a water treatment solutions company.
This list covers three chemical and sugar, diagnostic and water stocks with complete current figures: DCM Shriram, Vijaya Diagnostic Centre and Ion Exchange (India). Every figure comes from the latest reported financials and the 9 November 2026 market close. Companies without complete current figures were left out.
Click Here – Get Free Investment Predictions
What Are Chemical and Sugar, Diagnostic and Water Stocks?
Chemical and sugar, diagnostic and water stocks are listed companies that produce chemicals, sugar, plastics and agri inputs, run diagnostic laboratories and imaging centres, and supply ion exchange resins and water treatment systems. Their earnings depend on chemical and farm demand, test volumes and water project orders.
Chemical and Sugar, Diagnostic and Water Stocks at a Glance
| Company | CMP (Rs) | Market Cap (Rs Cr) | P/E | Industry P/E | ROE (%) | D/E |
|---|---|---|---|---|---|---|
| DCM Shriram | 911.75 | 14,257 | 10.3 | 13.9 | 16.3 | 0.24 |
| Vijaya Diagnostic Centre | 1,466.6 | 14,066 | 75.0 | 59.6 | 18.1 | 0.44 |
| Ion Exchange (India) | 313.95 | 5,397 | 55.2 | 22.7 | 10.7 | 0.36 |
On valuation, DCM Shriram trades at a P/E below the industry P/E, while Vijaya Diagnostic Centre and Ion Exchange (India) trade above it, which reflects the growth the market already expects. Readers comparing chemical and sugar, diagnostic and water stocks should look at return on equity and debt together, since a high return earned with low debt is easier to sustain.
Why Do Chemical and Sugar, Diagnostic and Water Stocks Have a Strong Roadmap in India?
Chemical and sugar, diagnostic and water stocks have a strong roadmap in India because steady demand for chemicals and farm inputs, wider access to diagnostics and heavy spending on water treatment keep widening the market for these companies.
- Chemicals and agri. Farms and factories need steady inputs.
- Diagnostics. Patients seek affordable tests and imaging.
- Water treatment. Industry needs clean process water.
Why DCM Shriram Features Among These Chemical and Sugar, Diagnostic and Water Stocks
Among the chemical and sugar, diagnostic and water stocks on this list, DCM Shriram is a diversified company with businesses in caustic soda and chemicals, sugar, fertilisers and agri inputs, and building products.
Revenue rose from Rs 9,719 crore in FY22 to Rs 13,734 crore in FY26, a compound annual growth rate of 9.0%. Net profit grew from Rs 447 crore in FY24 to Rs 856 crore in FY26, which works out to a compound annual growth rate of 38.4%.
The company has a return on equity of 16.3%, a debt to equity ratio of 0.24 and a market capitalisation of Rs 14,257 crore. The stock trades at a P/E of 10.3, below the industry P/E of 13.9.
Roadmap: The company is expanding its chemicals capacity and widening its range of agri inputs and value-added products. A mix of chemicals and agri businesses spreads its sources of revenue.
What to watch: Monitor chemical prices, sugar output and demand for agri inputs.
Why Vijaya Diagnostic Centre Features Among These Chemical and Sugar, Diagnostic and Water Stocks
Among the agri chemical, lab and water solution shares on this list, Vijaya Diagnostic Centre is a Hyderabad-headquartered diagnostics chain that offers pathology and radiology services through a network of centres, with Hyderabad and Telangana as its home base.
In the June 2026 quarter, revenue grew 22.8% year on year to Rs 240 crore, while net profit rose 37.6% to Rs 53.1 crore. Revenue rose from Rs 475 crore in FY22 to Rs 835 crore in FY26, a compound annual growth rate of 15.1%.
Net profit grew from Rs 111 crore in FY22 to Rs 173 crore in FY26, which works out to a compound annual growth rate of 11.8%. The company has a return on equity of 18.1%, a debt to equity ratio of 0.44 and a market capitalisation of Rs 14,066 crore. The stock trades at a P/E of 75.0, above the industry P/E of 59.6.
Roadmap: The plan is to deepen its network in existing clusters and extend the Vijaya brand into new regions, adding imaging modalities and wellness packages that raise revenue per patient. Diagnostics is a fragmented business, so organised chains with strong brands keep gaining share.
What to watch: Check the revenue contribution from newer regions and the pace at which new centres turn profitable.
Why Ion Exchange (India) Features Among These Chemical and Sugar, Diagnostic and Water Stocks
Among the three companies on this list, Ion Exchange (India) provides water and wastewater treatment solutions, including chemicals, resins, engineering projects and consumer water purifiers, for industries, municipalities and homes.
The company has a return on equity of 10.7%, a debt to equity ratio of 0.36 and a market capitalisation of Rs 5,397 crore. The stock trades at a P/E of 55.2, above the industry P/E of 22.7.
Revenue rose from Rs 1,619 crore in FY22 to Rs 3,001 crore in FY26, a compound annual growth rate of 16.7%. Net profit for FY26 was Rs 143 crore, a net margin of 4.8%. In the June 2026 quarter, revenue grew 17.6% year on year to Rs 706 crore.
Roadmap: The company benefits from tighter water reuse and discharge norms, which lift demand for treatment plants and recycling systems. A mix of projects, chemicals and consumer products spreads its revenue.
What to watch: Track order inflows in water projects, chemicals demand and consumer product growth.
DCM Shriram vs Vijaya Diagnostic Centre vs Ion Exchange (India) on Key Financials
The table below sets the three chemical and sugar, diagnostic and water stocks side by side on revenue, profit and margin, using reported figures.
| Company | FY22 Revenue (Rs Cr) | FY26 Revenue (Rs Cr) | Revenue CAGR (FY22-FY26) | FY26 Net Profit (Rs Cr) | FY26 Net Margin |
|---|---|---|---|---|---|
| DCM Shriram | 9,719 | 13,734 | 9.0% | 856 | 6.2% |
| Vijaya Diagnostic Centre | 475 | 835 | 15.1% | 173 | 20.7% |
| Ion Exchange (India) | 1,619 | 3,001 | 16.7% | 143 | 4.8% |
Vijaya Diagnostic Centre posts the highest return on equity in this group at 18.1%. DCM Shriram has the largest FY26 revenue at Rs 13,734 crore, and Ion Exchange (India) shows the fastest revenue growth with a 16.7% compound annual rate. A useful habit with chemical and sugar, diagnostic and water stocks is to check each new quarterly result against the capacity plans the company described earlier.
Key Risks to Check Before Investing in Chemical and Sugar, Diagnostic and Water Stocks
Every theme carries risks that deserve a check before any decision. For these chemical and sugar, diagnostic and water stocks, the main points are: Long-term agri chemical, lab and water solution shares holders usually track revenue growth, margins and cash flow side by side rather than relying on a single ratio.
- Raw material and energy costs. Input prices can move margins in chemicals.
- Test volumes. Footfall and test mix can vary with seasons.
- Valuation levels. Some of these companies trade at high earnings multiples, so growth must continue to justify them.
Treat this list as a starting point for research and not as a recommendation. Read the latest results presentation, check the management commentary on order books or capacity plans, and compare each company with its peers before you decide anything.
Use the Univest Stock Screener to filter chemical and sugar, diagnostic and water stocks by market capitalisation, P/E, ROE and growth, and build your own shortlist.
Final Thoughts on Chemical and Sugar, Diagnostic and Water Stocks
Chemical and sugar, diagnostic and water stocks reward investors who follow demand trends, order books and margins together. DCM Shriram, Vijaya Diagnostic Centre and Ion Exchange (India) each have a clear plan to grow. Based on the 9 November 2026 close, DCM Shriram trades at Rs 911.75, Vijaya Diagnostic Centre at Rs 1,466.6 and Ion Exchange (India) at Rs 313.95. Valuation matters as much as growth, so compare each company’s P/E with its industry P/E before adding any of these chemical and sugar, diagnostic and water stocks to a watchlist.
Download the Univest iOS App or Univest Android App to track chemical and sugar, diagnostic and water stocks, set price alerts and get research-backed stock ideas.
Disclaimer: Data and figures in this article are sourced from publicly available information. These may or may not be accurate. Please verify all data with the official NSE (nseindia.com) and BSE (bseindia.com) websites before making any investment decision. Investments in securities are subject to market risk. This content is for educational purposes only and is not investment advice by Univest (SEBI RA INH000013776).
What are chemical and sugar, diagnostic and water stocks?
Ans. Chemical and sugar, diagnostic and water stocks are listed companies that produce chemicals, sugar, plastics and agri inputs, run diagnostic laboratories and imaging centres, and supply ion exchange resins and water treatment systems. Their earnings depend on chemical and farm demand, test volumes and water project orders. This list looks at three of them, DCM Shriram, Vijaya Diagnostic Centre and Ion Exchange (India), using reported FY22 to FY26 financials and the 9 November 2026 closing prices.
Which chemical and sugar, diagnostic and water stocks are covered in this list?
Ans. This list covers DCM Shriram, Vijaya Diagnostic Centre and Ion Exchange (India). Based on the 9 November 2026 close, DCM Shriram traded at Rs 911.75, Vijaya Diagnostic Centre at Rs 1,466.6 and Ion Exchange (India) at Rs 313.95. Their return on equity ranges from 10.7% to 18.1%, and their revenue compound annual growth from FY22 to FY26 ranges from 9.0% to 16.7%.
Why do chemical and sugar, diagnostic and water stocks have a strong future roadmap in India?
Ans. Chemical and sugar, diagnostic and water stocks have a strong roadmap in India because steady demand for chemicals and farm inputs, wider access to diagnostics and heavy spending on water treatment keep widening the market for these companies. The main drivers are as follows. Chemicals and agri. Farms and factories need steady inputs. Diagnostics. Patients seek affordable tests and imaging. Water treatment. Industry needs clean process water. Together these factors give the companies on this list a visible path for growth over the coming years.
How has DCM Shriram performed financially?
Ans. Revenue rose from Rs 9,719 crore in FY22 to Rs 13,734 crore in FY26, a compound annual growth rate of 9.0%. Net profit grew from Rs 447 crore in FY24 to Rs 856 crore in FY26, which works out to a compound annual growth rate of 38.4%. The company has a return on equity of 16.3%, a debt to equity ratio of 0.24 and a market capitalisation of Rs 14,257 crore. The stock trades at a P/E of 10.3, below the industry P/E of 13.9. Looking ahead, the company is expanding its chemicals capacity and widening its range of agri inputs and value-added products. A mix of chemicals and agri businesses spreads its sources of revenue.
How has Vijaya Diagnostic Centre performed financially?
Ans. Revenue rose from Rs 475 crore in FY22 to Rs 835 crore in FY26, a compound annual growth rate of 15.1%. Net profit grew from Rs 111 crore in FY22 to Rs 173 crore in FY26, which works out to a compound annual growth rate of 11.8%. In the June 2026 quarter, revenue grew 22.8% year on year to Rs 240 crore, while net profit rose 37.6% to Rs 53.1 crore. The company has a return on equity of 18.1%, a debt to equity ratio of 0.44 and a market capitalisation of Rs 14,066 crore. The stock trades at a P/E of 75.0, above the industry P/E of 59.6. Looking ahead, the plan is to deepen its network in existing clusters and extend the Vijaya brand into new regions, adding imaging modalities and wellness packages that raise revenue per patient. Diagnostics is a fragmented business, so organised chains with strong brands keep gaining share.
How has Ion Exchange (India) performed financially?
Ans. Revenue rose from Rs 1,619 crore in FY22 to Rs 3,001 crore in FY26, a compound annual growth rate of 16.7%. Net profit for FY26 was Rs 143 crore, a net margin of 4.8%. In the June 2026 quarter, revenue grew 17.6% year on year to Rs 706 crore. The company has a return on equity of 10.7%, a debt to equity ratio of 0.36 and a market capitalisation of Rs 5,397 crore. The stock trades at a P/E of 55.2, above the industry P/E of 22.7. Looking ahead, the company benefits from tighter water reuse and discharge norms, which lift demand for treatment plants and recycling systems. A mix of projects, chemicals and consumer products spreads its revenue.
What risks should investors check before buying chemical and sugar, diagnostic and water stocks?
Ans. Investors should check a few risks before buying chemical and sugar, diagnostic and water stocks. Raw material and energy costs. Input prices can move margins in chemicals. Test volumes. Footfall and test mix can vary with seasons. Valuation levels. Some of these companies trade at high earnings multiples, so growth must continue to justify them. Reading the latest results presentation and comparing each company with its peers helps judge how these risks apply to each stock.
Is this list of chemical and sugar, diagnostic and water stocks investment advice?
Ans. No. This article is educational and uses publicly available data as of the 9 November 2026 close. Please verify figures on NSE and BSE, read company filings and consult a SEBI registered adviser before investing. Univest is SEBI registered research analyst INH000013776.
